(Q34519242)

2 August 2017

1 reference

title

Treatment and prevention of infective endocarditis (English)

1 reference

2 August 2017

François Delahaye

1

1 reference

2 August 2017

Bruno Hoen

2

1 reference

2 August 2017

Eugène McFadden

3

1 reference

2 August 2017

Olivier Roth

4

1 reference

2 August 2017

Guy de Gevigney

5

1 reference

2 August 2017

language of work or name

English

0 references

publication date

1 February 2002

1 reference

Expert Opinion on Pharmacotherapy

2 August 2017

1 reference

2 August 2017

3

1 reference

2 August 2017

2

1 reference

2 August 2017

131-145

1 reference

Antibiotic treatment of adults with infective endocarditis due to streptococci, enterococci, staphylococci, and HACEK microorganisms. American Heart Association

2 August 2017

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.2.131

Treatment of endocarditis with teicoplanin: a retrospective analysis of 104 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.2.131

Treatment of right-sided Staphylococcus aureus endocarditis in intravenous drug users with ciprofloxacin and rifampicin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.2.131

Lack of bactericidal effect of antibiotics except aminoglycosides on Bartonella (Rochalimaea) henselae

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.2.131

Activities of the combination of quinupristin-dalfopristin with rifampin in vitro and in experimental endocarditis due to Staphylococcus aureus strains with various phenotypes of resistance to macrolide-lincosamide-streptogramin antibiotics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.2.131

Treatment of endocarditis due to vancomycin-resistant Enterococcus faecium with quinupristin/dalfopristin, doxycycline, and rifampin: a synergistic drug combination

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.2.131

Efficacy of linezolid in a staphylococcal endocarditis rabbit model

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.2.131

Linezolid therapy of vancomycin-resistant Enterococcus faecium experimental endocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.2.131

Successful treatment of vancomycin-resistant Enterococcus endocarditis with oral linezolid

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.2.131

Activity of LY333328 combined with gentamicin in vitro and in rabbit experimental endocarditis due to vancomycin-susceptible or -resistant Enterococcus faecalis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.2.131

Bactericidal activities of two daptomycin regimens against clinical strains of glycopeptide intermediate-resistant Staphylococcus aureus, vancomycin-resistant Enterococcus faecium, and methicillin-resistant Staphylococcus aureus isolates in an in vi

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.2.131

In vivo activity of evernimicin (SCH 27899) against methicillin-resistant Staphylococcus aureus in experimental infective endocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.2.131

In vivo activities of evernimicin (SCH 27899) against vancomycin-susceptible and vancomycin-resistant enterococci in experimental endocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.2.131

Tricuspid valve endocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.2.131

Allograft aortic root replacement in prosthetic aortic valve endocarditis: a review of 32 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.2.131

Treatment of aortic valve endocarditis with the Ross operation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.2.131

Surgical treatment of prosthetic valve endocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.2.131

Does prophylaxis prevent postdental infective endocarditis? A controlled evaluation of protective efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.2.131

Efficacy of antibiotic prophylaxis for prevention of native-valve endocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.2.131

Chemoprophylaxis for bacterial endocarditis--a survey of current practice in London

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.2.131

Prevention of Infective Endocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.2.131

21 January 2018

Identifiers

DOI

10.1517/14656566.3.2.131

1 reference

release_xlink2vt3fhljghy4ooioiy56q

2 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/xlink2vt3fhljghy4ooioiy56q

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference